Gene Center Munich, Department of Biochemistry, University of Munich, Munich, Germany.
Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Science. 2020 Sep 4;369(6508):1249-1255. doi: 10.1126/science.abc8665. Epub 2020 Jul 17.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the current coronavirus disease 2019 (COVID-19) pandemic. A major virulence factor of SARS-CoVs is the nonstructural protein 1 (Nsp1), which suppresses host gene expression by ribosome association. Here, we show that Nsp1 from SARS-CoV-2 binds to the 40 ribosomal subunit, resulting in shutdown of messenger RNA (mRNA) translation both in vitro and in cells. Structural analysis by cryo-electron microscopy of in vitro-reconstituted Nsp1-40 and various native Nsp1-40 and -80 complexes revealed that the Nsp1 C terminus binds to and obstructs the mRNA entry tunnel. Thereby, Nsp1 effectively blocks retinoic acid-inducible gene I-dependent innate immune responses that would otherwise facilitate clearance of the infection. Thus, the structural characterization of the inhibitory mechanism of Nsp1 may aid structure-based drug design against SARS-CoV-2.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)是当前 2019 年冠状病毒病(COVID-19)大流行的病原体。SARS-CoV 的主要毒力因子是非结构蛋白 1(Nsp1),它通过核糖体结合抑制宿主基因表达。在这里,我们表明来自 SARS-CoV-2 的 Nsp1 与 40S 核糖体亚基结合,导致体外和细胞内信使 RNA(mRNA)翻译关闭。通过体外重建的 Nsp1-40 和各种天然 Nsp1-40 和 -80 复合物的冷冻电子显微镜结构分析表明,Nsp1 的 C 末端结合并阻塞了 mRNA 进入隧道。因此,Nsp1 有效地阻止了视黄酸诱导基因 I 依赖性先天免疫反应,否则这些反应将有助于清除感染。因此,Nsp1 抑制机制的结构特征可能有助于针对 SARS-CoV-2 的基于结构的药物设计。